
reviewed and agreed with the ﬁnal document before societal review and subsequent submission for endorsement. All members of the working group undertook
Level 1 GRADE training, and the several working group
members undertook Guideline Methodology training
(McMaster University).

ACKNOWLEDGEMENTS
We would like to thank the following external experts
for their review of our PICOs for clinical relevance and
the guideline document: Sriram Narayanan (Singapore),
Rica Tanaka (Japan), Ismail Cassimjee (South Africa), Xu
Jun (China), Heidi Corcoran (Hong Kong), Yamile Jubiz
(Colombia), Tsvetalina Tankova (Bulgaria), and our patient representatives. Production of the 2023 IWGDF
Guidelines was supported by unrestricted grants from:

1128

Fitridge et al

Journal of Vascular Surgery
November 2023

Advanced Oxygen Therapy Inc., Essity, Mölnlycke, Reapplix, and Urgo Medical. These sponsors did not have
any communication related to the systematic reviews
of the literature or related to the guidelines with working
group members during the writing of the guidelines and
have not seen any guideline or guideline-related document before publication.

REFERENCES
1. Bus SA. Standards for the development and methodology of the
2023 International Working Group on the Diabetic Foot guidelines.
Diabetes Metab Res Rev 2023. doi: 10.1002/dmrr.3267. [Online
ahead of print].
2. Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A.
GRADE guidelines: a new series of articles in the Journal of Clinical
Epidemiology. J Clin Epidemiol 2011;64:380-2.
3. Current care guidelines: peripheral arterial disease. Duodecim
2010;126:1433-4.
4. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items
for systematic reviews and meta-analyses: the PRISMA statement.
BMJ 2009;339:b2535.
5. Chuter VH, Schaper N, Mills J, H